News
Home > News > News
- 2024/01/11CCSB obtained US patent for Tofacitinib Citrate
- 2023/01/17CCSB obtained US patent for Etelcalcetide
- 2023/01/12CCSB accomplished Trandolapril audit.
- 2022/12/20CCSB accomplished Methocarbamol remote audit.
- 2022/11/18CCSB accomplished an inspection of The Food and Drug Administration (USFDA).
- 2022/10/12CCSB accomplished Rapamycin remote audit
- 2022/09/21CCSB accomplished Tacrolimus remote audit.
- 2022/09/16CCSB accomplished EVE and Rapamycin remote audit.
- 2022/08/04CCSB accomplished Sugammadex Sodiumaudit.
- 2022/07/28Obtained Outstanding Company of the year, 2022 Taiwan BIO awards
